Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Regenxbio Inc
About RGNX
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address an array of diseases. It is focused on its internal development pipeline in three areas: retinal, neuromuscular, and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202, RGX-121, and RGX-111. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). It is developing RGX-121 for the treatment of Mucopolysaccharidosis type II (MPS II), and RGX-111 to treat Mucopolysaccharidosis Type I.
Find out what a historical investment in Regenxbio Inc would be worth today using our RGNX stock calculator.
Market Capitalisation
$295.71M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.35M
High today
$6.48
Low today
$5.71
Open price
$6.25
52-week high
$16.19
52-week low
$6.02
Ready to start your investing journey with Stake?
Open an accountHow do I buy RGNX shares in Australia?
Buying RGNX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Regenxbio Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RGNX
What is the ticker symbol of Regenxbio Inc?
The ticker symbol for Regenxbio Inc is RGNX.
How much is one share of RGNX?
One share of RGNX is valued at $5.73 as of 16 May 2026.
What is the market capitalisation of Regenxbio Inc RGNX?
As of 16 May 2026 Regenxbio Inc has a market cap of $295.71M.
What is the 52-week high for Regenxbio Inc stock?
The Regenxbio Inc 52-week high stock price is $16.19.
What is the 52-week low for Regenxbio Inc stock?
The Regenxbio Inc 52-week low stock price is $6.02.
Can I buy RGNX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RGNX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RGNX on Stake
- Buy RGNX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RGNX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RGNX related stocks